简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Research
HOME
·
Software ETF
Harvest CSI Software Services ETF(159852) Falls 2.27% in Early Trading; Institutions: "Lobster Effect" to Significantly Boost Long-Term Demand for Intelligent Computing Centers
Tags:
ETF
159852.SZ
Software ETF
2026-03-13
AI Application Commercialization Possesses Vast Development Space,Harvest CSI Software Services ETF(159852) Falls Over 3%
Tags:
ETF
159852.SZ
Software ETF
2026-01-15
AI+ Drives Industrial Software Market Toward 500 Billion Yuan Scale,Guotai CSI All Share Software ETF (515230) Surges Over 4% in Morning Trading
Tags:
Software ETF
515230.SH
ETF
2026-01-12
AI Industry Value Center Accelerates Shift to Agent Application Layer, Harvest CSI Software Services ETF(159852) Up Nearly 3%
Tags:
ETF
Software ETF
159852.SZ
NewTimeSpace
2026-01-09
Harvest CSI Software Services ETF (159852) Rises 2.01%, Aiming for Eighth Consecutive Gain
Tags:
Software ETF
159852.SZ
ETF
2026-01-06
Featured News
Finance
Estun (02715.HK): Positive Profit Forecast, Interim Net Profit Attributable to Parent Expected to Surge Around 21 to 26 Times
Finance
CHINA DEVELOPMENT BANK FINANCIAL LEASING(01606.HK): Acquisition of Three Vessels at Consideration Not Exceeding USD 138 Million
Finance
Holly Futures(03678.HK): Independent Director Zhang Hongfa Resigns
Finance
Shenwan Hongyuan (06806.HK): Shenwan Hongyuan Securities Obtains Registration Approval for Perpetual Subordinated Bonds with a Ceiling of RMB 30 Billion
Finance
Luxxu Group(01327.HK): Executive Director Yang Xi Resigns; Liang Yanhuang Appointed as Authorised Representative
Finance
United Laboratories (03933.HK): New Specification of Sodium Hyaluronate Eye Drops Approved for Marketing
Finance
Dongjiang Environmental (00895.HK): 2026 Interim Performance Forecast, Expected Net Loss of RMB 250 Million to RMB 270 Million
Finance
CSPC Pharmaceutical Group (01093.HK): Albumin-Bound Docetaxel Combined with Anitumab Granted Breakthrough Therapy Designation
Finance
China Everbright Water (01857.HK): Completes Issuance of Phase 1 Medium-Term Notes of 2026 with Principal of RMB 1.5 Billion
Finance
MicroTech Medical(02235.HK): Continuous Glucose Monitoring System Secures Marketing Approval in South Korea
Scan QR Code
Download App